Cargando…
Ebola Virus Glycoprotein Induces an Innate Immune Response In vivo via TLR4
Ebola virus (EBOV), a member of the Filoviridae family, causes the most severe form of viral hemorrhagic fever. Although no FDA licensed vaccine or treatment against Ebola virus disease (EVD) is currently available, Ebola virus glycoprotein (GP) is the major antigen used in all candidate Ebola vacci...
Autores principales: | Lai, Chih-Yun, Strange, Daniel P., Wong, Teri Ann S., Lehrer, Axel T., Verma, Saguna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562721/ https://www.ncbi.nlm.nih.gov/pubmed/28861075 http://dx.doi.org/10.3389/fmicb.2017.01571 |
Ejemplares similares
-
Adjuvants Differentially Modulate the Immunogenicity of Lassa Virus Glycoprotein Subunits in Mice
por: To, Albert, et al.
Publicado: (2022) -
RIG-I and MDA5 are modulated by bone morphogenetic protein (BMP6) and are essential for restricting Zika virus infection in human Sertoli cells
por: Jiyarom, Boonyanudh, et al.
Publicado: (2023) -
Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?
por: Roe, Kelsey, et al.
Publicado: (2014) -
CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization
por: Haun, Brien K., et al.
Publicado: (2020) -
Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle
por: Furuyama, Wakako, et al.
Publicado: (2022)